INDSWFTLTDNSEInd-Swift Limited· PharmaceuticalsMediumNegative
Announced Wed, 9 Jul · 16:53 IST
The Exchange has sought clarification from Ind-Swift Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Regulatory & Legal
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
NSE has asked Ind-Swift Limited to clarify a compliance issue regarding its financial results for the quarter ended 31-March-2025. The discrepancy is that the financial results submitted by the company did not follow the format prescribed by SEBI under Regulation 33 of the Listing Obligations and Disclosure Requirements Regulations, 2015. This is a procedural/formatting matter rather than a financial or governance concern. The company has not yet responded to the exchange's query.
Likely market impact
This is a routine compliance clarification request and is unlikely to materially impact the stock or shareholders. Investors should watch for the company's response to confirm the issue is resolved without escalation.